Torrent Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. It is the flagship company of the Torrent Group and is engaged in the research, manufacture and marketing of branded and generic pharmaceutical formulations. The company has a notable presence in therapeutic segments such as cardiovascular, central nervous system, gastrointestinal, diabetology, and women's healthcare.
Key facts
| Type | Public limited company |
|---|---|
| Industry | Pharmaceuticals |
| Headquarters | Ahmedabad, Gujarat, India |
| Parent | Torrent Group |
| Founder | U. N. Mehta |
| Listings | BSE, NSE |
| Country of origin | India |
Background
Torrent Pharmaceuticals traces its origin to a small enterprise founded by Uttamlal Naginlal Mehta (U. N. Mehta), who began the business with a focus on psychiatric medicines, an area that was relatively underserved in the Indian pharmaceutical market at the time. The company subsequently broadened its therapeutic portfolio and expanded into chronic disease management, particularly cardiovascular and metabolic disorders, which remain core areas of its business.
The Torrent Group, of which the pharmaceutical company is the flagship, also has interests in power generation and distribution through Torrent Power, and other diversified businesses.
Operations
Torrent Pharmaceuticals operates manufacturing facilities in India producing finished dosages and active pharmaceutical ingredients (APIs). It markets its products in India and across multiple international markets, including the United States, Brazil, Germany and other parts of Europe, as well as several emerging markets. The company has built a significant branded generics presence in Brazil and Germany through acquisitions and organic growth.
Research and development
The company maintains research and development centres focused on formulation development, generic product development, and process chemistry. Its R&D activities support filings of abbreviated new drug applications (ANDAs) for the United States market and dossier submissions for other regulated markets.
Acquisitions and growth
Torrent Pharmaceuticals has expanded through a series of acquisitions over the years, including the purchase of Heumann Pharma in Germany, which strengthened its position in the European generics market. In India, the company has acquired domestic formulation portfolios from other pharmaceutical companies to deepen its presence in chronic therapy areas, including the acquisition of the domestic formulations business of Unichem Laboratories.
Corporate social responsibility
The UNM Foundation, named after the company's founder U. N. Mehta, undertakes social initiatives in healthcare, education and community development. The U. N. Mehta Institute of Cardiology and Research Centre in Ahmedabad is associated with the legacy of the founder.
Significance
Torrent Pharmaceuticals is among the larger Indian pharmaceutical companies by revenue and is recognised for its leadership in branded chronic-therapy prescriptions in the Indian domestic market. Its international operations make it part of the cohort of Indian pharmaceutical multinationals that supply generics to regulated and semi-regulated markets worldwide.
Related topics
- Torrent Group
- Torrent Power
- Pharmaceutical industry in India
- Ahmedabad
- U. N. Mehta
- List of pharmaceutical companies in India
References
- Wikidata entry: Q12430250
- Official website of Torrent Pharmaceuticals Limited